Application 076009
- Type
- ANDA
- Sponsor
- CHARTWELL MOLECULES
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NABUMETONE | NABUMETONE | TABLET;ORAL | 500MG | No | No |
| 002 | NABUMETONE | NABUMETONE | TABLET;ORAL | 750MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 10544-273 | Nabumetone | Nabumetone | Blenheim Pharmacal, Inc. | ANDA | Current |
| 49884-649 | Nabumetone | Nabumetone | Par Pharmaceutical Inc | ANDA | Current |
| 49884-650 | Nabumetone | Nabumetone | Par Pharmaceutical Inc | ANDA | Current |
| 63874-607 | Nabumetone | Nabumetone | Altura Pharmaceuticals, Inc. | ANDA | Current |
| 63874-687 | Nabumetone | Nabumetone | Altura Pharmaceuticals, Inc. | ANDA | Current |